Skip to main content
Total Market Cap: $44,249,115,844 Volume (24h): $830,590,853

Cara Therapeutics Inc.

Cara Therapeutics Inc. (CARA) logo
Rank 15
About

Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.

Website
$12.0000
USD
-2.20%
Market cap
$557,012,400
Total volume
$2,851,020
Shares outstanding
46,417,700
Rank 15
Website
About

Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
Nasdaq
CARA
$2,851,020
100%
$12.0000
Chart
Social media

Share widget

Copy widget code
Subscribe to our newsletter